Dementia

Company to market animal model for Alzheimer disease

Published in Biotech Business Week, October 13th, 2003

Hemoxymed, Inc., (HMYD) plans to bring to market research animals that develop a key pathology researchers believe to be an essential characteristic of Alzheimer disease.

These animals, which are called htau transgenic mice, have a segment of human DNA inserted into their genes. As a result, they grow as mice while expressing certain genetic characteristics that resemble Alzheimer disease in humans.

According to Peter Davies, PhD, and Cathy Andorfer, PhD, of Albert Einstein College of Medicine, and Karen Duff, PhD, of the New York State Nathan S. Kline Research Institute, principal developers of the transgenic mice, "Currently, there are transgenic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2003-10-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry